Help ?

IGMIN: We're glad you're here. Please click 'create a new query' if you are a new visitor to our website and need further information from us.

If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click 'take me to my Query.'

Search

Organised by  IgMin Fevicon

Regional sites

Browse by Subjects

Welcome to IgMin Research – an Open Access journal uniting Biology, Medicine, and Engineering. We’re dedicated to advancing global knowledge and fostering collaboration across scientific fields.

Browse by Sections

At IgMin Research, we bridge the frontiers of Biology, Medicine, and Engineering to foster interdisciplinary innovation. Our expanded scope now embraces a wide spectrum of scientific disciplines, empowering global researchers to explore, contribute, and collaborate through open access.

Special Issues

Our vision is to catalyze cross-disciplinary ideas that drive rapid advancements in knowledge.

Members

Our vision is to catalyze cross-disciplinary ideas that drive rapid advancements in knowledge.

Articles

Our vision is to catalyze cross-disciplinary ideas that drive rapid advancements in knowledge.

Explore Content

Our vision is to catalyze cross-disciplinary ideas that drive rapid advancements in knowledge.

Identify Us

Our vision is to catalyze cross-disciplinary ideas that drive rapid advancements in knowledge.

IgMin Corporation

Welcome to IgMin, a leading platform dedicated to enhancing knowledge dissemination and professional growth across multiple fields of science, technology, and the humanities. We believe in the power of open access, collaboration, and innovation. Our goal is to provide individuals and organizations with the tools they need to succeed in the global knowledge economy.

Publications Support
[email protected]
E-Books Support
[email protected]
Webinars & Conferences Support
[email protected]
Content Writing Support
[email protected]
IT Support
[email protected]

Search

Select Language

Explore Section

Content for the explore section slider goes here.

Abstract

Abstract at IgMin Research

Our vision is to catalyze cross-disciplinary ideas that drive rapid advancements in knowledge.

Medicine Group Research Article Article ID: igmin358

Endoscopic Aspects of Lesions Secondary to Helicobacter pylori Infection in two Hospitals in Douala: A Cross-Sectional Study over a Three-year Period

Gastroenterology DOI10.61927/igmin358 Affiliation

Affiliation

    1Department of Biochemistry, Faculty of Science, University of Douala, Douala, Cameroon

    2Department of Internal Medicine, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon

    3Department of Clinical Biology, Faculty of Medicine and Pharmaceutical Sciences, University of Yaoundé I, Yaoundé, Cameroon

    4Department of Microbiology, Faculty of Science, University of Yaoundé I, Yaoundé, Cameroon

    5Department of Biochemistry, Faculty of Science, University of Dschang, Dschang, Cameroon

    6Department of Clinical Biology, Laquintinie Hospital of Douala, Douala, Cameroon

    7Department of Internal Medicine, Douala General Hospital, Douala, Cameroon

    8Department of Internal Medicine, Laquintinie Hospital of Douala, Douala, Cameroon

74
VIEWS
20
DOWNLOADS
Connect with Us

Abstract

Background: Helicobacter pylori infection is a major cause of gastroduodenal diseases and is strongly associated with gastric carcinogenesis. Endoscopy plays a key role in identifying mucosal lesions related to this infection. However, data on the endoscopic aspects of H. pylori–associated lesions remain scarce in Cameroon. This study aimed to describe the endoscopic features of lesions associated with Helicobacter pylori infection in two hospitals in Douala over a three-year period.
Methods: This analytical cross-sectional study included 842 patients who underwent upper gastrointestinal endoscopy with gastric biopsies. The diagnosis of H. pylori infection was established using histology (reference method), rapid urease testing, and bacterial culture. Histological lesions, including mononuclear and polymorphonuclear infiltration, glandular atrophy, and intestinal metaplasia, were assessed according to the updated Sydney classification and compared according to H. pylori infection status.
Results: The prevalence of H. pylori infection was 73.2% by histology, 67.7% by rapid urease test, and 42.9% by bacterial culture. The most common endoscopic lesions were superficial gastritis (28.4%) and erosive gastritis (22.3%), followed by duodenal ulcers (16.8%) and gastric ulcers (10%). The prevalence of H. pylori infection was particularly high in duodenal ulcers (91.9%), gastric ulcers (82.1%), and gastric cancer (100%). High positivity rates were also observed in superficial gastritis (70.7%), erosive gastritis (64.9%), and patients with normal endoscopic findings (63.6%). H. pylori infection was significantly associated (p < 0.01) with severe mononuclear and polymorphonuclear infiltration, glandular atrophy, and intestinal metaplasia.
Conclusion: This study confirms the high prevalence of H. pylori infection and its significant association with inflammatory, ulcerative, and precancerous gastric lesions. These findings support the major role of H. pylori in the pathophysiological cascade leading to gastric cancer and highlight the importance of early detection and eradication strategies.

References

    1. Bomme M, Hansen JM, Wildner-Christensen M, Hallas J, Schaffalitzky de Muckadell OB. Effects of community screening for Helicobacter pylori: 13-year follow-up evaluation of a randomized controlled trial. Clin Gastroenterol Hepatol. 2017;15(11):1715–1723.e7. doi:10.1016/j.cgh.2017.06.006
    2. Mitsui Y, Miyoshi A, Okamoto K, et al. Different phenotypes of gastric fundic gland polyposis and cancer in patients with familial adenomatous polyposis depending on Helicobacter pylori Gastric Cancer. 2019;22(6):1294–1300. doi:10.1007/s10120-019-01005-y
    3. Zullo A, Hassan C, Cristofari F, et al. Effects of Helicobacter pylori eradication on early-stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol. 2010;8(2):105–110. doi:10.1016/j.cgh.2009.07.017
    4. Huh CW, Kim BW. Diagnosis of Helicobacter pylori Korean J Gastroenterol. 2018;72(5):229–236. doi:10.4166/kjg.2018.72.5.229
    5. Malfertheiner P, Megraud F, O’Morain CA, et al. Management of Helicobacter pylori infection: the Maastricht V/Florence consensus report. Gut. 2017;66(1):6–30. doi:10.1136/gutjnl-2016-312288
    6. Sabbagh P, Mohammadnia-Afrouzi M, Javanian M, et al. Diagnostic methods for Helicobacter pylori infection: ideals, options, and limitations. Eur J Clin Microbiol Infect Dis. 2019;38(1):55–66. doi:10.1007/s10096-018-3414-4
    7. Lauwers GY, Fujita H, Nagata K, Shimizu M. Pathology of non-Helicobacter pylori gastritis: extending the histopathologic horizons. J Gastroenterol. 2010;45(2):131–145. doi:10.1007/s00535-009-0146-3
    8. Chatrangsun B, Vilaichone RK. Endoscopic diagnosis for Helicobacter pylori infection: white light imaging vs image-enhanced endoscopy. Asian Pac J Cancer Prev. 2021;22(9):3031–3038. doi:10.31557/APJCP.2021.22.9.3031
    9. Watanabe T, Nadatani Y, Suda W, et al. Long-term persistence of gastric dysbiosis after eradication of Helicobacter pylori in patients undergoing endoscopic submucosal dissection. Gastric Cancer. 2021;24(3):710–720. doi:10.1007/s10120-020-01141-w
    10. Tiwari A, Rai R, Dahal P, Regmi S. Prevalence of Helicobacter pylori in endoscopic gastric biopsies of chronic gastritis patients at a tertiary care centre. J Nepal Med Assoc. 2020;58(228):564–568. doi:10.31729/jnma.5210
    11. Wang Y, Shen L, Zhao G, et al. Histomorphological characteristics and pathological types of hyperproliferation of gastric surface epithelial cells. Gastroenterol Res Pract. 2021;2021:8828326. doi:10.1155/2021/8828326
    12. Wang YK, Zhou JL, Meng NL, Zhu CY, Wang SN, Chen XD. How does Helicobacter pylori infection cause gastric mucosal atrophy? Infect Drug Resist. 2022;15:3619–3629. doi:10.2147/IDR.S355981
    13. Suzuki H, Mori H. World trends for Helicobacter pylori eradication therapy and gastric cancer prevention strategy. J Gastroenterol. 2018;53(3):354–361. doi:10.1007/s00535-017-1407-1
    14. Khatoon J, Prasad KN, Rai RP, Ghoshal UC, Krishnani N. Association of heterogeneity of Helicobacter pylori cag pathogenicity island with peptic ulcer disease and gastric cancer. Br J Biomed Sci. 2017;74(3):121–126. doi:10.1080/09674845.2017.1278887
    15. Salar A. Gastric MALT lymphoma and Helicobacter pylori. Med Clin (Barc). 2019;152(2):65–71. doi:10.1016/j.medcli.2018.09.006
    16. Marques MS, Melo J, Cavadas B, et al. Afadin downregulation by Helicobacter pylori induces epithelial-to-mesenchymal transition in gastric cells. Front Microbiol. 2018;9:2712. doi:10.3389/fmicb.2018.02712
    17. Quach DT, Vilaichone RK, Vu KV, Yamaoka Y, Sugano K, Mahachai V. Helicobacter pylori infection and related gastrointestinal diseases in Southeast Asia: an expert opinion survey. Asian Pac J Cancer Prev. 2018;19(12):3565–3569. doi:10.31557/APJCP.2018.19.12.3565
    18. El-Zimaity HM, Graham DY. Evaluation of gastric biopsy site and number for identification of Helicobacter pylori: role of the Sydney system. Hum Pathol. 1999;30(1):72–77. doi:10.1016/S0046-8177(99)90303-9
    19. Udoh MO, Obaseki DE. Histopathological evaluation of Helicobacter pylori-associated gastric lesions in Benin City, Nigeria. East Afr Med J. 2012;89(12):408–413
    20. El-Serag HB, Kao JY, Kanwal F, et al. Houston consensus conference on testing for Helicobacter pylori infection in the United States. Clin Gastroenterol Hepatol. 2018;16(7):992–1002.e6. doi:10.1016/j.cgh.2018.03.013
    21. Horiuchi Y, Fujisaki J, Yamamoto N, et al. Biological behavior of Helicobacter pylori-negative early gastric cancer. Gastric Cancer. 2016;19(1):160–165. doi:10.1007/s10120-014-0452-1
    22. Take S, Mizuno M, Ishiki K, et al. Low incidence of esophageal adenocarcinoma after Helicobacter pylori eradication in Japan. Clin Gastroenterol Hepatol. 2018;16(12):1995–1996. doi:10.1016/j.cgh.2018.03.030
    23. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol. 1996;20(10):1161–1181
    24. Malfertheiner P, Megraud F, Rokkas T, Gisbert JP, Liou JM, Schulz C, et al. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. 2022;71(9):1724–1762
    25. Eusebi LH, Zagari RM, Bazzoli F. Epidemiology of Helicobacter pylori Best Pract Res Clin Gastroenterol. 2020;44–45:101704
    26. Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: treatment of Helicobacter pylori Am J Gastroenterol. 2017;112(2):212–239
    27. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. Cancer Res. 1992;52(24):6735–6740
    28. International Agency for Research on Cancer. Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum. 2012;100B:363–382
    29. Katelaris P, et al. Global epidemiology of peptic ulcer disease. World J Gastroenterol. 2020;26(29):4153–4163
    30. Bola S, et al. Profil endoscopique des affections gastroduodénales à Cotonou. Rev Afr Gastroenterol. 2019
    31. Mégraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev. 2007;20(2):280–322
    32. World Health Organization. Helicobacter pylori and gastric cancer classification. Geneva: WHO; 2017
    33. World Gastroenterology Organisation. Global guideline: Helicobacter pylori in developing countries. 2023
    34. Ka O, et al. Profil histologique et endoscopique de l’infection à Helicobacter pylori au Sénégal. Mali Med. 2018;33(3):32–38
    35. Plummer M, Franceschi S, Vignat J, Forman D, de Martel C. Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer. 2015;136(2):487–490
    36. Muteba J, et al. Profil endoscopique des gastrites à Kinshasa. Ann Afr Med. 2020
    37. Ndjitoyap Ndam EC, et al. Helicobacter pylori infection and upper gastrointestinal endoscopic findings in Cameroon. Pan Afr Med J. 2014;17:115
    38. Suzuki R, Shiota S, Yamaoka Y. Molecular epidemiology, population genetics, and pathogenic role of Helicobacter pylori. Infect. Genet. Evol. 2012; 12: 203–213. doi : 1016/j.meegid.2011.12.002
    39. Mentis A, Lehours P, Mégraud F. Epidemiology and Diagnosis of Helicobacter pylori infection. Helicobacter, 2015; 20: 1–7. doi : 10.1111/hel.12250

Similar Articles

Why publish with us?

  • Global Visibility – Indexed in major databases

  • Fast Peer Review – Decision within 14–21 days

  • Open Access – Maximize readership and citation

  • Multidisciplinary Scope – Biology, Medicine and Engineering

  • Editorial Board Excellence – Global experts involved

  • University Library Indexing – Via OCLC

  • Permanent Archiving – CrossRef DOI

  • APC – Affordable APCs with discounts

  • Citation – High Citation Potential

Submit Your Article

Advertisement